Table: Brightpath Biotherapeutics - 6-MTH parent results

BrightPath Biotherapeutics Co

14/11/2025 06:38

Nov 14 (Reuters)- 
             Brightpath Biotherapeutics Co., Ltd. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Sep 30, 2025        Sep 30, 2024      Mar 31, 2026  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             0 mln               0 mln             0 mln     
                 (-40.0 pct)         (+25.0 pct)       (-87.6 pct)  
  Operating     loss 464 mln        loss 542 mln        loss 1.18   
  Recurring     loss 460 mln        loss 537 mln        loss 1.16   
  Net           loss 462 mln        loss 538 mln        loss 1.17   
  EPS           loss 4.53 yen       loss 7.11 yen    loss 12.88 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T